Responses
Clinical and epidemiological research
Extended report
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
Compose a Response to This Article
Other responses
No responses have been published for this article.